As the FDA’s investigation continued, they ultimately decided to issue an involuntary recall, pulling all prescription and ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been ... the drug in the early 1980s and sold it as a prescription and over-the-counter (OTC) product for indications ...

In March, they declined, and the amended complaint was filed on May 20. [3] Zantac was one of GSK’s most successful products, the first prescription drug in history to reach $1 billion in sales ...

Get detailed information on Ranitidine, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

GSK launched Zantac in 1981 and it was first approved for sale in the US in 1983 as a prescription medication. It went on to become the world's best-selling drug, with annual sales in excess of $1bn.

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

U.S. FDA calling for Zantac to be pulled from market immediately As the FDA’s investigation continued, they ultimately decided to issue an involuntary recall, pulling all prescription and over ...